| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.12 | 0.02 |